Nucleic acid respiratory syncytial virus vaccines

Details Nucleic acid respiratory syncytial virus vaccines Nucleic acid respiratory syncytial virus vaccines

1997-05-01

1999-03-09

Elliott, George C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

435914, A61K 3170, C12N 1564

Patent

active

058801049

ABSTRACT:
Vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described. Such vectors also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such vectors may be used to immunize a host, including a human host, by administration thereto. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.

REFERENCES:
patent: 5589466 (1996-12-01), Felgner et al.
Chanock, Robert M. et al, Pediatrics vol. 90 No. 1, Jul. 1992, pp. 137-142.
Prince et al, J. Virol., 61:1851-1854. Jun. 1987.
Crowe et al, PNAS 91:1386-1390. Feb. 1994.
Prince et al, J. Virol. 55:517 Sep. 1985; Virus Res. 3; 193-206. Oct. 1985.
Groothuis et al, N. Engl. J. Med. 329:1524-1530. Nov. 1993.
Walsh et al, J. Infec. Dis., 155: 1198-1204. Jun. 1987.
Paradiso et al, Pediatr. Infect. Dis. J. 13:792-798. Sep. 1994.
Hemming et al, J. Infect. Dis., 152:1083-1087 (1985).
Lounsbah et al, Journal of General Virology 74, 2559-2565 (1993).
Wathan et al. (Feb. 1989) Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector. J. Infect. Dis. 159:255-264.
Wertz et al. (Feb. 1987) Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J. Virol. 61:293-301.
Tang et al. (May 1993) High-level and erythroid-specific expression of human glucose-6-phosphate dehydrogenase in transgenic mice. J. Biol. Chem. 268:9522-9525.
Collis et al. (1990) Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J. 9:233-240.

Affiliated with

Also associated with

Rating

Nucleic acid respiratory syncytial virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid respiratory syncytial virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid respiratory syncytial virus vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1321223